PubMed Health⌕ Search

Biomedical subjects

D M Knight

Publications and source records attributed to D M Knight.

27 records · Page 2Linked to original sources

Analysis of gene expression during differentiation of adipogenic cells in culture and hormonal control of the developmental program.

Treatment of 10T1/2 mouse embryo fibroblasts with 5-azacytidine, an inhibitor of mammalian DNA methylation, leads to the appearance of several new cell types, including adipocytes. We have isolated several such adipogenic cell lines and characterized two of them, TA1 and TA2. When subconfluent these cells resemble fibroblasts. After growth is arrested at high density, both clones express a functional adipose phenotype characterized by accumulation of lipid droplets. This in vitro differentiation is accompanied by a greater than 100-fold increase in glycerol phosphate dehydrogenase activity, an enzyme characteristic of mature adipocytes. Consistent with these morphologic and enzymatic changes, differentiated TA1 cells show a widespread alteration in protein composition as well as a substantial change in the pattern of secreted proteins. We have constructed a cDNA library of TA1 adipocytes and have isolated 12 different cDNA clones corresponding to mRNAs that are induced during adipogenesis. Among these RNAs, some are not expressed prior to initiating differentiation whereas others are expressed in 10T1/2 cells and TA1 preadipocytes. Treatment of TA1 cells with insulin and the synthetic glucocorticoid dexamethasone leads to an acceleration of the phenotypic changes observed during adipogenesis. We have found that hormone treatment leads to a precocious accumulation of specific RNA for all of the clones studied. Analysis of the temporal control of RNA accumulation during differentiation indicates that there are different categories of RNAs, some of which accumulate by day 1 after treatment while others are not apparent until day 3.

Adipose Tissue↗

Control of phage lambda development by stability and synthesis of cII protein: role of the viral cIII and host hflA, himA and himD genes.

The cII protein of bacteriophage lambda has a decisive role in the regulatory switch between the lysogenic and lytic pathways of viral development. Recent work has indicated that cII may be the primary control function providing for the initial partition between the two pathways, with other host and viral regulatory genes acting to determine the levels of cII in an infected cell. We have studied the synthesis and stability of cII protein with two experimental systems, phage infection and a cII-producing plasmid. We have found that the stability of cII is controlled by the host hflA and viral cIII genes; hflA protein facilitates degradation of cII, whereas cIII protects cII. The synthesis of cII appears to be under the positive control of the host himA and himD genes. We conclude that posttranscriptional regulation of cII by host and viral genes is critical for the choice of a developmental pathway.

Bacteriophage lambda↗

Regulation of Escherichia coli ornithine transcarbamylase by orotate.

Ornithine transcarbamylase from Escherichia coli, strain W, exhibits negative cooperativity with respect to ornithine, and the enzymatic activity is further regulated by orotate. The effect of orotate on ornithine transcarbamylase is dependent not only upon the carbamylphosphate concentration, but also upon the concentration of ornithine. At high concentrations of carbamylphosphate (10 mM), a conversion from negative cooperativity to positive cooperativity is observed with 10 mM orotate. At 1 mM carbamylphosphate, however, 10 mM orotate activates the enzyme at low ornithine concentrations, but as the ornithine concentration is increased above 5 mM, inhibition is observed. Thus, a regulatory link has been established between the pathways of arginine biosynthesis and pyrimidine biosynthesis, each of which utilizes carbamylphosphate.

Carbamyl Phosphate↗

The vital flame.

Explore the source record for details and available documents.

Biochemistry↗